Use of modified intention-to-treat analysis in studies of direct oral anticoagulants and risk of selection bias: a systematic review
10.1136/bmjebm-2018-111057
February 11, 2019
General Medicine
Lorcaserin in obesity: minimal benefits and ill-defined harms
10.1136/bmjebm-2018-111128
January 30, 2019
Clinicians’ cognitive biases: a potential barrier to implementation of evidence-based clinical practice
10.1136/bmjebm-2018-111074
December 28, 2018
Inclusion and exclusion criteria and the problem of describing homogeneity of study populations in clinical trials
10.1136/bmjebm-2018-111115
December 19, 2018
Drug discovery today: no molecules required
10.1136/bmjebm-2018-111121
December 6, 2018
Catalogue of bias: publication bias
10.1136/bmjebm-2018-111107
December 6, 2018
Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear
10.1136/bmjebm-2018-111096
December 5, 2018
Individuals with high-risk adenomas are at elevated risk for colorectal cancer
10.1136/bmjebm-2018-111087
November 14, 2018
Transparency of the UK medicines regulator: auditing freedom of information requests and reasons for refusal
10.1136/bmjebm-2018-111018
October 30, 2018
Understanding Risk for Better Stroke Prevention
10.1136/bmjebm-2018-111089
October 29, 2018